[Antiemetic efficacy of the repeated use of granisetron in multiple cycles of anti-cancer chemotherapy].
Twenty-three patients with gynecological cancer who were treated with 85 cycles of cytotoxic chemotherapy containing platinum received intravenous granisetron repeatedly. Granisetron (3 mg/body) was drip-infused twice for each cycle at a 24-hour interval. The antiemetic efficacy was evaluated and compared for each day and each cycle, and analysed using the chi-square and H tests. There were no significant differences between the first cycle and the subsequent second through fifth cycles in the severity of nausea and the frequency of vomiting. The latter tended to increase in the second day of each cycle. These results indicated that granisetron does not decrease in antiemetic efficacy by repeated administration during multiple cycles of anti-cancer chemotherapy.
Tanioka
Y
Y
Dept. of Obstetrics and Gynecology, Chugoku District Cancer Center, Kure National Hospital.
Fujii
T
T
Nakata
N
N
Nakagawa
H
H
Tanimoto
H
H
Kioka
H
H
Naito
H
H
D016190:Carboplatin / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D017829:Granisetron / Q000008:administration & dosage*; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000188:drug therapy* / Q000517:prevention & control
D016190:Carboplatin; D002945:Cisplatin; D017829:Granisetron